Sarepta Therapeutics, Inc. (SRPT)
17.16
+0.50
(+3.00%)
USD |
NASDAQ |
Mar 17, 11:29
Sarepta Therapeutics Shareholders Equity (Quarterly) : 1.141B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| REGENXBIO, Inc. | 102.73M |
| Keros Therapeutics, Inc. | 303.13M |
| Gilead Sciences, Inc. | 22.70B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.350B |
| Total Liabilities (Quarterly) | 2.209B |
| Debt to Equity Ratio | 0.9114 |
| Current Ratio | 2.317 |
| Net Debt Paydown Yield | 3.17% |